advertisement

WGW-2021

14 Costing studies; pharmacoeconomics (20)

Showing records 1 to 20

Display all abstracts in classification 14 Costing studies; pharmacoeconomics

Search within classification 14 Costing studies; pharmacoeconomics
86302 Assessing Health Care Burden in Glaucoma Patients with and Without Physical or Mental Comorbidities
Serbin M
Journal of managed care & specialty pharmacy 2020; 26: 325-331
86166 Health Economic Analysis in Glaucoma
Park I
Journal of Glaucoma 2020; 29: 304-311
86785 Influence of Cost of Care and Adherence in Glaucoma Management: An Update
Meier-Gibbons F
Journal of Ophthalmology 2020; 2020: 5901537
86349 Acceptability, adherence and economic analyses of a new clinical pathway for the identification of non-responders to glaucoma eye drops: a prospective observational study
Waterman H
British Journal of Ophthalmology 2020; 0:
86784 The Use of Generic Medications for Glaucoma
Tatham AJ
Journal of Ophthalmology 2020; 2020: 1651265
86574 Prostaglandin Coverage and Costs to Medicare and Medicare Beneficiaries, 2009-2017
Bartlett VL
Journal of managed care & specialty pharmacy 2020; 26: 562-567
86349 Acceptability, adherence and economic analyses of a new clinical pathway for the identification of non-responders to glaucoma eye drops: a prospective observational study
Read S
British Journal of Ophthalmology 2020; 0:
86574 Prostaglandin Coverage and Costs to Medicare and Medicare Beneficiaries, 2009-2017
Liu P
Journal of managed care & specialty pharmacy 2020; 26: 562-567
86302 Assessing Health Care Burden in Glaucoma Patients with and Without Physical or Mental Comorbidities
Devine B
Journal of managed care & specialty pharmacy 2020; 26: 325-331
86166 Health Economic Analysis in Glaucoma
Gale J
Journal of Glaucoma 2020; 29: 304-311
86785 Influence of Cost of Care and Adherence in Glaucoma Management: An Update
Töteberg-Harms M
Journal of Ophthalmology 2020; 2020: 5901537
86574 Prostaglandin Coverage and Costs to Medicare and Medicare Beneficiaries, 2009-2017
Dhruva SS
Journal of managed care & specialty pharmacy 2020; 26: 562-567
86166 Health Economic Analysis in Glaucoma
Skalicky SE
Journal of Glaucoma 2020; 29: 304-311
86302 Assessing Health Care Burden in Glaucoma Patients with and Without Physical or Mental Comorbidities
Campbell J
Journal of managed care & specialty pharmacy 2020; 26: 325-331
86349 Acceptability, adherence and economic analyses of a new clinical pathway for the identification of non-responders to glaucoma eye drops: a prospective observational study
Morgan JE; Gillespie D
British Journal of Ophthalmology 2020; 0:
86574 Prostaglandin Coverage and Costs to Medicare and Medicare Beneficiaries, 2009-2017
Shah ND
Journal of managed care & specialty pharmacy 2020; 26: 562-567
86302 Assessing Health Care Burden in Glaucoma Patients with and Without Physical or Mental Comorbidities
Basu A
Journal of managed care & specialty pharmacy 2020; 26: 325-331
86349 Acceptability, adherence and economic analyses of a new clinical pathway for the identification of non-responders to glaucoma eye drops: a prospective observational study
Nollett C
British Journal of Ophthalmology 2020; 0:
86574 Prostaglandin Coverage and Costs to Medicare and Medicare Beneficiaries, 2009-2017
Bollinger KE; Ross JS
Journal of managed care & specialty pharmacy 2020; 26: 562-567
86349 Acceptability, adherence and economic analyses of a new clinical pathway for the identification of non-responders to glaucoma eye drops: a prospective observational study
Allen D; Weiss M; Anderson P
British Journal of Ophthalmology 2020; 0:

Issue 21-2

Change Issue


advertisement

WGC-2021